The company offers a range of services including in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, next generation sequencing, bioinformatics, and ex vivo assays. Gubra works with partners and customers from big pharma, biotech, and academia, focusing on developing drugs and treatments for obesity, diabetes, NASH, and diabetic complications. They have established themselves as a highly professional and competent partner in the market through their commitment to high quality, scientific excellence, speed, and teamwork. Gubra was founded in 2008 and is based in Horsholm, Denmark.